Characteristics of 273 Patients With NHL
| Characteristic . | No. (%) . |
|---|---|
| Sex | |
| Male | 133 (49) |
| Female | 140 (51) |
| Age | |
| ≤60 yrs | 161 (59) |
| >60 yrs | 112 (41) |
| Performance status (ECOG score) | |
| <2 | 216 (79) |
| ≥2 | 57 (21) |
| Ann Arbor stage | |
| I, II | 73 (27) |
| III, IV | 200 (73) |
| No. of extranodal sites | |
| <2 | 190 (70) |
| ≥2 | 83 (30) |
| Serum LDH level | |
| ≤1 × normal | 146 (55) |
| >1 × normal | 119 (45) |
| Unknown | 8 |
| Serum β2-microglobulin level | |
| ≤3.0 mg/mL | 168 (66) |
| >3.0 mg/mL | 86 (34) |
| Unknown | 19 |
| Serum albumin level | |
| ≥35.0 g/L | 215 (85) |
| <35.0 g/L | 38 (15) |
| Unknown | 20 |
| B symptoms | |
| Absent | 205 (75) |
| Present | 68 (25) |
| Histology | |
| Lymphocytic/lymphoplasmocytoid | 22 |
| Follicular | 96 |
| Mucosal-associated (MALT) | 2 |
| Marginal zone | 7 |
| Mantle cell | 18 |
| Diffuse large cell | 126 |
| Burkitt cell | 2 |
| Characteristic . | No. (%) . |
|---|---|
| Sex | |
| Male | 133 (49) |
| Female | 140 (51) |
| Age | |
| ≤60 yrs | 161 (59) |
| >60 yrs | 112 (41) |
| Performance status (ECOG score) | |
| <2 | 216 (79) |
| ≥2 | 57 (21) |
| Ann Arbor stage | |
| I, II | 73 (27) |
| III, IV | 200 (73) |
| No. of extranodal sites | |
| <2 | 190 (70) |
| ≥2 | 83 (30) |
| Serum LDH level | |
| ≤1 × normal | 146 (55) |
| >1 × normal | 119 (45) |
| Unknown | 8 |
| Serum β2-microglobulin level | |
| ≤3.0 mg/mL | 168 (66) |
| >3.0 mg/mL | 86 (34) |
| Unknown | 19 |
| Serum albumin level | |
| ≥35.0 g/L | 215 (85) |
| <35.0 g/L | 38 (15) |
| Unknown | 20 |
| B symptoms | |
| Absent | 205 (75) |
| Present | 68 (25) |
| Histology | |
| Lymphocytic/lymphoplasmocytoid | 22 |
| Follicular | 96 |
| Mucosal-associated (MALT) | 2 |
| Marginal zone | 7 |
| Mantle cell | 18 |
| Diffuse large cell | 126 |
| Burkitt cell | 2 |